retatrutide fda approval status november 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation The FDA has issued warning

Obstructions can cause severe abdominal pain, vomiting, bloating, and the inability to pass gas or have a bowel movement

Cagrilintide + retatrutide adds the amylin analog cagrilintide to reinforce satiety - useful when hunger is the main barrier

HR decision-makers are closely following the surge in demand for the medications, intently considering their plans, and seeking more information from trusted sources to help them reach a decision

A provider who cuts corners might sell a vial labeled "10 mg" that contains significantly less of the target peptide

Understanding GLP-1 Medications To appreciate the importance of vitamins while on GLP-1 medications, its essential to understand how these drugs work

It is possible to get a prescription for GLP-1 online, such as through MEDvidi, but you must first attend a virtual appointment to discuss your health status and medical history